前列腺癌分子改变与MRI特征的关联
研究纳入62个大于0.5厘米的前列腺癌结节,术前均行多参数MRI(mpMRI),检测ERG重排、PTEN缺失、SPINK1过表达、SPOP突变和CHD1缺失,并与PI-RADSv2评分匹配。所有CHD1缺失结节在mpMRI上均不可见(P=0.037),SPINK1过表达结节均可见但未达统计学显著(P=0.06),各分子改变与PI-RADS评分严重程度无显著关联。
要点
- 所有CHD1缺失的前列腺癌结节在mpMRI上均不可见(P=0.037)。
- 所有SPINK1过表达的结节在mpMRI上均可见,但关联未达统计学显著(P=0.06)。
- 各分子改变与PI-RADS评分严重程度均无显著关联(所有P>0.05)。
核心结论
- 本研究首次描述前列腺癌复发分子改变与mpMRI结节特征之间的关联,可作为假设生成研究,供未来严格评估特定前列腺癌分子亚类与影像特征关联。
研究设计与样本
- 研究纳入62个大于0.5厘米的前列腺癌结节,术前均行mpMRI,评估ERG重排、PTEN缺失、SPINK1过表达、SPOP突变和CHD1缺失,并由单一观察者按PI-RADSv2量表评分。
主要发现
- 62个结节中,22个(35.5%)为ERG阳性,6个(9.7%)有SPINK1过表达,6个(9.7%)有SPOP突变,4个(6.5%)有CHD1缺失,1个(1.6%)有PTEN缺失。
- 所有CHD1缺失的结节在mpMRI上均不可见(P=0.037)。
- 所有SPINK1过表达的结节在mpMRI上均可见,但关联未达统计学显著(P=0.06)。
- 任何分子改变与PI-RADS评分严重程度之间均无显著关联(所有P>0.05)。
关键数值与推荐
- CHD1缺失与mpMRI不可见相关(P=0.037)。
- SPINK1过表达与mpMRI可见相关(P=0.06,未达统计学显著)。
- 分子改变与PI-RADS评分严重程度无显著关联(所有P>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) has been increasingly used for prostate cancer (PCa). Recent studies identified distinct molecular subclasses of PCa with recurrent genomic alterations. However, the associations between molecular alterations in PCa and characteristics on mpMRI are unknown. Therefore, the objective of this study was to investigate recurrent molecular alterations in PCa and their associations with mpMRI features. METHODS: Sixty-two PCa nodules >0.5 cm had a preoperative mpMRI. Nodules were evaluated for ERG rearrangement, PTEN deletion, SPINK1 overexpression, SPOP mutation and CHD1 deletion. Each PCa focus was matched to the corresponding location on mpMRI. Lesions were scored by single observer according to the PI-RADSv2 scale. RESULTS: Of the 62 nodules, 22 (35.5%) were ERG positive, 6 (9.7%) had SPINK1 overexpression, 6 (9.7%) had SPOP mutations, 4 (6.5%) had CHD1 deletions and 1 (1.6%) had PTEN deletion. All of the nodules with CHD1 deletions were not visible on mpMRI (P=0.037). All of the nodules with SPINK1 overexpression were visible on mpMRI, although the association was not statistically significant (P=0.06). There were no significant associations between any molecular alteration with the severity of the PI-RADS scores (all P>0.05). CONCLUSIONS: This investigation represents the first description of an association between recurrent molecular alterations and the characterization of PCa nodules on mpMRI. This study can be considered hypothesis-generating for future studies to rigorously evaluate the association of specific PCa molecular subclasses with imaging features and potentially define specific subsets of PCa for which the utility of MRI is higher or lower.
引用
- Lee D, Fontugne J, Gumpeni N, et al. Molecular alterations in prostate cancer and association with MRI features. Prostate Cancer Prostatic Dis. 2017. PMID: 28762374. doi:10.1038/pcan.2017.33
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。